ArticleJAMA surgery2020

Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.

Giampaolo Perri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.